By:
On:
In: Fair company, Stock analysis
Tagged:
With: 0 Comments

Company name Verisign, Inc.
Stock ticker VRSN
Live stock price [stckqut]VRSN[/stckqut]
P/E compared to competitors Good

MANAGEMENT EXECUTION

Employee productivity Good
Sales growth Poor
EPS growth Good
P/E growth Poor
EBIT growth Good

ANALYSIS

Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $95.08
Target stock price (averages with growth) $114.46
Target stock price (averages with no growth) $81.59
Target stock price (manual assumptions) $79.58

The following company description is from Google Finance: http://www.google.com/finance?q=vrsn

VeriSign, Inc. (VeriSign) is a provider of Internet infrastructure services. The Company provides network confidence and availability for mission-critical Internet services, such as domain name registry services and infrastructure assurance services. Its service capabilities enable real-time name resolution for a number of global top level domains (TLDs), enable domain name registration through registrars, and provide security intelligence and cloud-based network availability services to enterprise customers. It has one reportable segment is Naming Services, which consists of Registry Services and Network Intelligence and Availability (NIA) Services. It has operations inside as well as outside the United States (U.S.). Registry Services operates the authoritative directory of all .com, .net, .cc, .tv, and .name domain names and the back-end systems for all .gov, .jobs and .edu domain names.

 

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in Verisign, Inc. as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor.

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(s2member_level1)]
In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

Stock price at the time of the calculation: $61.45

Growth: 0.16

Current EPS (TTM): $2.26

P/E: 27

Future EPS Calc: $4.74

Future Stock Price Calc: $128.16

Target stock price: $79.57

I hope that this makes you a better investor. [/s2If]

By:
On:
In: Fair company, Stock analysis
Tagged:
With: 0 Comments

Company name GlaxoSmithKline plc (ADR)
Stock ticker GSK
Live stock price [stckqut]GSK[/stckqut]
P/E compared to competitors Good

MANAGEMENT EXECUTION

Employee productivity Fair
Sales growth Poor
EPS growth Good
P/E growth Good
EBIT growth Fair

ANALYSIS

Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $53.11
Target stock price (averages with growth) $56.37
Target stock price (averages with no growth) $45.17
Target stock price (manual assumptions) $52.6

The following company description is from Google Finance: http://www.google.com/finance?q=gsk

GlaxoSmithKline plc (GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. GSK’s principal pharmaceutical products include medicines in therapeutic areas: respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, antibacterials, oncology and emesis, dermatology, rare diseases, immuno-inflammation, vaccines and human immunodeficiency virus (HIV). The Company operates in three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare. On January 30, 2013, GSK acquired additional 29.3% interest in GlaxoSmithKline Consumer Healthcare Ltd. In May 2013, GlaxoSmithKline PLC acquired Okairos AG. In December 2013, Suntory Beverage & Food Ltd fully acquired Lucozade Ribena Suntory Limited from GlaxoSmithKline plc.

 

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in GlaxoSmithKline plc (ADR) as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor.

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(s2member_level1)]
In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

Stock price at the time of the calculation: $53.03

Growth: 0.1

Current EPS (TTM): $2.63

P/E: 20

Future EPS Calc: $4.23

Future Stock Price Calc: $84.71

Target stock price: $52.6

I hope that this makes you a better investor. [/s2If]

By:
On:
In: Fair company, Stock analysis
Tagged:
With: 0 Comments

Company name AMCON Distributing Co.
Stock ticker DIT
Live stock price [stckqut]DIT[/stckqut]
P/E compared to competitors Good

MANAGEMENT EXECUTION

Employee productivity Good
Sales growth Poor
EPS growth Poor
P/E growth Good
EBIT growth Poor

ANALYSIS

Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $81.29
Target stock price (averages with growth) $64.86
Target stock price (averages with no growth) $43.08
Target stock price (manual assumptions) $81.45

The following company description is from Google Finance: http://www.google.com/finance?q=dit

AMCON Distributing Company (AMCON) operates in two segments: wholesale distribution segment (Wholesale Segment) and retail health food segment (Retail Segment). The Company’s Wholesale Segment distributes consumer products in the Central, Rocky Mountain, and Southern regions of the United States. Its retail health food segment (Retail Segment) operates 14 health food retail stores located throughout the Midwest and Florida. During the fiscal year ended September 30, 2012 (fiscal 2012), sales of cigarettes represented 73% of the Company’s consolidated revenue. During fiscal 2012, sales of candy, beverages, food service, groceries, health food products, paper products, health and beauty care products, and tobacco products represented approximately 27% of consolidated revenue.

 

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in AMCON Distributing Co. as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor.

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(s2member_level1)]
In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

Stock price at the time of the calculation: $80.69

Growth: 0.1

Current EPS (TTM): $9.05

P/E: 9

Future EPS Calc: $14.57

Future Stock Price Calc: $131.17

Target stock price: $81.45

I hope that this makes you a better investor. [/s2If]

By:
On:
In: Fair company, Stock analysis
Tagged:
With: 0 Comments

Company name Mastercard Inc
Stock ticker MA
Live stock price [stckqut]MA[/stckqut]
P/E compared to competitors Fair

MANAGEMENT EXECUTION

Employee productivity Good
Sales growth Fair
EPS growth Good
P/E growth Poor
EBIT growth Good

ANALYSIS

Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $1285.82
Target stock price (averages with growth) $2410.71
Target stock price (averages with no growth) $2359.6
Target stock price (manual assumptions) $1135.68

The following company description is from Google Finance: http://www.google.com/finance?q=ma

MasterCard Incorporated (MasterCard) is a global payments and technology company that connects consumers, financial institutions, merchants, Governments and businesses worldwide, enabling them to use electronic forms of payment instead of cash and checks. The Company offers a range of payment solutions that enable its customers and partners to develop and implement credit, debit, prepaid and related payment programs for their customers. Its customers and partners include financial institutions and other entities that act as issuers and acquirers, merchants, Government entities, telecommunications companies and other businesses. MasterCard manages a family of payment brands, including MasterCard, Maestro and Cirrus, which the Company license to its customers for use in their payment programs and solutions. On April 15, 2011, MasterCard acquired the prepaid card program management operations of Travelex Holdings Ltd., since renamed Access Prepaid Worldwide.

 

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in Mastercard Inc as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor.

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(s2member_level1)]
In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

Stock price at the time of the calculation: $832.42

Growth: 0.17

Current EPS (TTM): $25.28

P/E: 33

Future EPS Calc: $55.42

Future Stock Price Calc: $1829.02

Target stock price: $1135.68

I hope that this makes you a better investor. [/s2If]

By:
On:
In: Fair company, Stock analysis
Tagged:
With: 0 Comments

Company name The Gap Inc.
Stock ticker GPS
Live stock price [stckqut]GPS[/stckqut]
P/E compared to competitors Good

MANAGEMENT EXECUTION

Employee productivity Fair
Sales growth Poor
EPS growth Good
P/E growth Fair
EBIT growth Fair

ANALYSIS

Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $37.3
Target stock price (averages with growth) $49.49
Target stock price (averages with no growth) $44.24
Target stock price (manual assumptions) $140.62

The following company description is from Google Finance: http://www.google.com/finance?q=gps

The Gap, Inc. (Gap Inc.) is a global specialty apparel company. Gap Inc. offers apparel, accessories, and personal care products for men, women, children, and babies under the Gap, Old Navy, Banana Republic, Piperlime, and Athleta brands. It operates in two segments: Stores, which includes the operations of the retail stores for Gap, Old Navy, and Banana Republic, and Direct, which includes the operations for its online brands, both domestic and international. It has Company-operated stores in the United States, Canada, the United Kingdom, France, Ireland, Japan, China, and Italy. It also has franchise agreements with unaffiliated franchisees to operate Gap and Banana Republic stores throughout Asia, Australia, Eastern Europe, Latin America, the Middle East, and Africa. As of January 28, 2012, the Company had 3,263 store locations, of which 3,036 stores were Company-operated and 227 stores were franchise store locations. In March 2012, the Company opened its store in South Africa.

 

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in The Gap Inc. as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor.

For owners of my book, “The Confident Investor” I offer the following analysis (you must be logged in to this site as a book owner in order to see the following analysis). If you have registered and cannot see the balance of this article, make sure you are logged in and refresh your browser.
[s2If current_user_can(s2member_level1)]
In order to assist you in using the techniques of this book, the values that I used when calculating the Manual pricing above were:

Stock price at the time of the calculation: $38.98

Growth: 0.11

Current EPS (TTM): $2.8

P/E: 48

Future EPS Calc: $4.71

Future Stock Price Calc: $226.47

Target stock price: $140.62

I hope that this makes you a better investor. [/s2If]